(IRS) IRSA Inversiones Y - Overview
Exchange: NYSE •
Country: Argentina •
Currency: USD •
Type: Common Stock •
ISIN: US4500472042
Stock: Shopping Malls, Offices, Hotels, Residential Developments, Digital Platform
Total Rating 48
Risk 54
Buy Signal -0.41
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.05% |
| Yield on Cost 5y | 53.20% |
| Yield CAGR 5y | 96.32% |
| Payout Consistency | 30.8% |
| Payout Ratio | 0.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.0% |
| Relative Tail Risk | -7.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | 12.18 |
| Character TTM | |
|---|---|
| Beta | 0.944 |
| Beta Downside | 0.888 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.01% |
| CAGR/Max DD | 1.70 |
Description: IRS IRSA Inversiones Y January 19, 2026
IRSA Inversiones y Representaciones S.A. (NYSE: IRS) is Argentina’s largest diversified real-estate operator, active across five segments: shopping malls, office buildings, residential sales & development, luxury hotels, and ancillary services such as its digital loyalty platform ¡appa!. The firm acquires, develops, and leases commercial and hospitality assets, while also holding undeveloped land for future projects. IRSA is a wholly-owned subsidiary of agribusiness group Cresud S.A.C.I.F. y A., and has been listed on the NYSE since 2017.
Key quantitative drivers (FY 2024) include an average mall occupancy of ≈ 95 % and a weighted rental yield of ≈ 8 % across its office and retail portfolio, both of which have been resilient despite Argentina’s hyperinflation (CPI ≈ 250 % YoY). Hotel occupancy has risen to ~ 78 % as international tourism rebounds, supporting RevPAR growth of ~ 12 % YoY. The company’s exposure to USD-linked leases provides a partial hedge against local currency depreciation, but earnings remain sensitive to sovereign debt negotiations and the country’s fiscal stance.
For a deeper, data-driven valuation, you may find the ValueRay platform’s granular cash-flow models useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 474.64b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.33 > 1.0 |
| NWC/Revenue: -20.90% < 20% (prev -13.68%; Δ -7.22% < -1%) |
| CFO/TA 0.06 > 3% & CFO 138.09b > Net Income 474.64b |
| Net Debt (418.82b) to EBITDA (508.75b): 0.82 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.5m) vs 12m ago 15.29% < -2% |
| Gross Margin: 35.28% > 18% (prev 0.64%; Δ 3464 % > 0.5%) |
| Asset Turnover: 21.76% > 50% (prev 18.06%; Δ 3.70% > 0%) |
| Interest Coverage Ratio: 9.86 > 6 (EBITDA TTM 508.75b / Interest Expense TTM 40.64b) |
Altman Z'' 1.01
| A: -0.04 (Total Current Assets 271.33b - Total Current Liabilities 380.25b) / Total Assets 2501.81b |
| B: -0.00 (Retained Earnings -2.00b / Total Assets 2501.81b) |
| C: 0.17 (EBIT TTM 400.51b / Avg Total Assets 2394.15b) |
| D: 0.16 (Book Value of Equity 206.80b / Total Liabilities 1265.27b) |
| Altman-Z'' Score: 1.01 = BB |
Beneish M -2.06
| DSRI: 0.88 (Receivables 83.74b/75.82b, Revenue 521.06b/413.05b) |
| GMI: 1.81 (GM 35.28% / 63.91%) |
| AQI: 1.01 (AQ_t 0.87 / AQ_t-1 0.87) |
| SGI: 1.26 (Revenue 521.06b / 413.05b) |
| TATA: 0.13 (NI 474.64b - CFO 138.09b) / TA 2501.81b) |
| Beneish M-Score: -2.06 (Cap -4..+1) = BB |
What is the price of IRS shares?
As of February 07, 2026, the stock is trading at USD 16.14 with a total of 139,692 shares traded.
Over the past week, the price has changed by -7.24%, over one month by +1.13%, over three months by +22.60% and over the past year by +25.64%.
Over the past week, the price has changed by -7.24%, over one month by +1.13%, over three months by +22.60% and over the past year by +25.64%.
Is IRS a buy, sell or hold?
IRSA Inversiones Y has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy IRS.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.3 | 32.2% |
| Analysts Target Price | 21.3 | 32.2% |
| ValueRay Target Price | 26.6 | 64.6% |
IRS Fundamental Data Overview February 07, 2026
P/E Trailing = 3.6946
P/S = 0.0026
P/B = 1.002
Revenue TTM = 521.06b USD
EBIT TTM = 400.51b USD
EBITDA TTM = 508.75b USD
Long Term Debt = 586.38b USD (from longTermDebt, last quarter)
Short Term Debt = 227.95b USD (from shortTermDebt, last quarter)
Debt = 455.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 418.82b USD (from netDebt column, last quarter)
Enterprise Value = 364.43b USD (1.30b + Debt 455.48b - CCE 92.34b)
Interest Coverage Ratio = 9.86 (Ebit TTM 400.51b / Interest Expense TTM 40.64b)
EV/FCF = 2.64x (Enterprise Value 364.43b / FCF TTM 138.08b)
FCF Yield = 37.89% (FCF TTM 138.08b / Enterprise Value 364.43b)
FCF Margin = 26.50% (FCF TTM 138.08b / Revenue TTM 521.06b)
Net Margin = 91.09% (Net Income TTM 474.64b / Revenue TTM 521.06b)
Gross Margin = 35.28% ((Revenue TTM 521.06b - Cost of Revenue TTM 337.25b) / Revenue TTM)
Gross Margin QoQ = 62.66% (prev 61.39%)
Tobins Q-Ratio = 0.15 (Enterprise Value 364.43b / Total Assets 2501.81b)
Interest Expense / Debt = 2.78% (Interest Expense 12.65b / Debt 455.48b)
Taxrate = 21.0% (US default 21%)
NOPAT = 316.40b (EBIT 400.51b * (1 - 21.00%))
Current Ratio = 0.71 (Total Current Assets 271.33b / Total Current Liabilities 380.25b)
Debt / Equity = 0.39 (Debt 455.48b / totalStockholderEquity, last quarter 1156.47b)
Debt / EBITDA = 0.82 (Net Debt 418.82b / EBITDA 508.75b)
Debt / FCF = 3.03 (Net Debt 418.82b / FCF TTM 138.08b)
Total Stockholder Equity = 1306.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.82% (Net Income 474.64b / Total Assets 2501.81b)
RoE = 36.33% (Net Income TTM 474.64b / Total Stockholder Equity 1306.64b)
RoCE = 21.16% (EBIT 400.51b / Capital Employed (Equity 1306.64b + L.T.Debt 586.38b))
RoIC = 15.37% (NOPAT 316.40b / Invested Capital 2058.10b)
WACC = 2.21% (E(1.30b)/V(456.78b) * Re(9.39%) + D(455.48b)/V(456.78b) * Rd(2.78%) * (1-Tc(0.21)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 6.35%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈93.70b ; Y1≈115.59b ; Y5≈196.85b
Fair Price DCF = 68.6k (EV 5732.37b - Net Debt 418.82b = Equity 5313.55b / Shares 77.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 25.36 | EPS CAGR: 12.91% | SUE: 0.0 | # QB: 0
Revenue Correlation: 83.31 | Revenue CAGR: 135.1% | SUE: -0.56 | # QB: 0
EPS current Year (2026-06-30): EPS=0.07 | Chg30d=-0.067 | Revisions Net=+1 | Growth EPS=-44.3% | Growth Revenue=+2.6%
EPS next Year (2027-06-30): EPS=0.57 | Chg30d=+0.427 | Revisions Net=+1 | Growth EPS=+760.9% | Growth Revenue=+7.3%
P/S = 0.0026
P/B = 1.002
Revenue TTM = 521.06b USD
EBIT TTM = 400.51b USD
EBITDA TTM = 508.75b USD
Long Term Debt = 586.38b USD (from longTermDebt, last quarter)
Short Term Debt = 227.95b USD (from shortTermDebt, last quarter)
Debt = 455.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 418.82b USD (from netDebt column, last quarter)
Enterprise Value = 364.43b USD (1.30b + Debt 455.48b - CCE 92.34b)
Interest Coverage Ratio = 9.86 (Ebit TTM 400.51b / Interest Expense TTM 40.64b)
EV/FCF = 2.64x (Enterprise Value 364.43b / FCF TTM 138.08b)
FCF Yield = 37.89% (FCF TTM 138.08b / Enterprise Value 364.43b)
FCF Margin = 26.50% (FCF TTM 138.08b / Revenue TTM 521.06b)
Net Margin = 91.09% (Net Income TTM 474.64b / Revenue TTM 521.06b)
Gross Margin = 35.28% ((Revenue TTM 521.06b - Cost of Revenue TTM 337.25b) / Revenue TTM)
Gross Margin QoQ = 62.66% (prev 61.39%)
Tobins Q-Ratio = 0.15 (Enterprise Value 364.43b / Total Assets 2501.81b)
Interest Expense / Debt = 2.78% (Interest Expense 12.65b / Debt 455.48b)
Taxrate = 21.0% (US default 21%)
NOPAT = 316.40b (EBIT 400.51b * (1 - 21.00%))
Current Ratio = 0.71 (Total Current Assets 271.33b / Total Current Liabilities 380.25b)
Debt / Equity = 0.39 (Debt 455.48b / totalStockholderEquity, last quarter 1156.47b)
Debt / EBITDA = 0.82 (Net Debt 418.82b / EBITDA 508.75b)
Debt / FCF = 3.03 (Net Debt 418.82b / FCF TTM 138.08b)
Total Stockholder Equity = 1306.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.82% (Net Income 474.64b / Total Assets 2501.81b)
RoE = 36.33% (Net Income TTM 474.64b / Total Stockholder Equity 1306.64b)
RoCE = 21.16% (EBIT 400.51b / Capital Employed (Equity 1306.64b + L.T.Debt 586.38b))
RoIC = 15.37% (NOPAT 316.40b / Invested Capital 2058.10b)
WACC = 2.21% (E(1.30b)/V(456.78b) * Re(9.39%) + D(455.48b)/V(456.78b) * Rd(2.78%) * (1-Tc(0.21)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 6.35%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈93.70b ; Y1≈115.59b ; Y5≈196.85b
Fair Price DCF = 68.6k (EV 5732.37b - Net Debt 418.82b = Equity 5313.55b / Shares 77.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 25.36 | EPS CAGR: 12.91% | SUE: 0.0 | # QB: 0
Revenue Correlation: 83.31 | Revenue CAGR: 135.1% | SUE: -0.56 | # QB: 0
EPS current Year (2026-06-30): EPS=0.07 | Chg30d=-0.067 | Revisions Net=+1 | Growth EPS=-44.3% | Growth Revenue=+2.6%
EPS next Year (2027-06-30): EPS=0.57 | Chg30d=+0.427 | Revisions Net=+1 | Growth EPS=+760.9% | Growth Revenue=+7.3%